We are live on
!
Find out more
B
Bellecapital Portfolio holdings
AUM
$625M
Turnover
41.45%
1-Year Est. Return
39.69%
This Fund
S&P 500
This Quarter
Est. Return
+5.95%
1 Year Est. Return
+39.69%
3 Year Est. Return
+127.77%
5 Year Est. Return
+155.51%
10 Year Est. Return
+530.96%
AUM
$114M
AUM Growth
+$5.96M
(+5.5%)
Cap. Flow
+$1.42M
Cap. Flow
% of AUM
1.24%
Top 10 Holdings %
Top 10 Hldgs %
48.81%
Holding
78
New
3
Increased
13
Reduced
18
Closed
7
Avg Time Held
1.5
years
Top 10 Avg Time Held
0.7
years
Top 20 Avg Time Held
1.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$5.07M |
| 2 |
WisdomTree Japan Hedged Equity Fund
DXJ
|
+$2.66M |
| 3 |
State Street SPDR S&P International Small Cap ETF
GWX
|
+$1.51M |
| 4 |
JD.com
JD
|
+$970K |
| 5 |
Alibaba
BABA
|
+$778K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$3.22M |
| 2 |
Cisco
CSCO
|
+$2.07M |
| 3 |
Pfizer
PFE
|
+$1.03M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$991K |
| 5 |
McKesson
MCK
|
+$851K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.97% |
| 2 | Consumer Discretionary | 16.41% |
| 3 | Healthcare | 15.86% |
| 4 | Communication Services | 14.66% |
| 5 | Technology | 12.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
Novartis
NVS
$286B
| $316K | 0.28% |
4,224
| – | – |
2017 Q1
1 quarter
|
|
52
Berkshire Hathaway Class B
BRK.B
$1.13T
| $312K | 0.27% |
1,840
| – | – |
2016 Q2
4 quarters
|
|
53
Applied Materials
AMAT
$341B
| $310K | 0.27% |
7,500
| – | – |
2016 Q2
4 quarters
|
|
54
iShares MSCI Brazil ETF
EWZ
$11.6B
| $308K | 0.27% |
9,025
| – | – |
2016 Q2
4 quarters
|
|
|
LFC
55
DELISTED
China Life Insurance Company Ltd.
LFC
| $297K | 0.26% |
19,380
| – | – |
2016 Q2
4 quarters
|
|
56
BHP
BHP
$211B
| $294K | 0.26% |
14,159
| – | – |
2016 Q2
4 quarters
|
|
|
ABB
57
DELISTED
ABB Ltd
ABB
| $287K | 0.25% |
11,535
| – | – |
2016 Q4
2 quarters
|
|
58
iShares Preferred and Income Securities ETF
PFF
$12.1B
| $258K | 0.23% |
6,575
| – | – |
2016 Q4
2 quarters
|
|
59
Berkshire Hathaway Class A
BRK.A
$1.13T
| $255K | 0.22% |
1
| – | – |
2016 Q1
5 quarters
|
|
60
Vanguard Short-Term Corporate Bond ETF
VCSH
$44B
| $251K | 0.22% |
3,130
| – | – |
2016 Q4
2 quarters
|
|
61
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.75B
| $244K | 0.21% |
+7,840
| New | +$254K |
2017 Q2
0 quarters
|
|
62
Verizon
VZ
$184B
| $238K | 0.21% |
5,319
| – | – |
2016 Q4
2 quarters
|
|
63
Barclays
BCS
$76B
| $237K | 0.21% |
23,491
+2,178
| +10% | +$22.2K |
2016 Q3
3 quarters
|
|
64
Block Inc
XYZ
$48B
| $235K | 0.21% |
10,000
| – | – |
2015 Q4
6 quarters
|
|
65
Kimberly-Clark
KMB
$34.6B
| $230K | 0.2% |
1,780
| – | – |
2016 Q1
5 quarters
|
|
|
CHL
66
DELISTED
China Mobile Limited
CHL
| $228K | 0.2% |
4,300
| – | – |
2017 Q1
1 quarter
|
|
|
AXJL
67
DELISTED
WisdomTree Asia-Pacific ex-Japan Fund
AXJL
| $226K | 0.2% |
3,444
| – | – |
2017 Q1
1 quarter
|
|
68
Elme Communities
ELME
$156M
| $211K | 0.18% |
6,600
| – | – |
2016 Q4
2 quarters
|
|
69
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.17B
| $204K | 0.18% |
2,550
| – | – |
2017 Q1
1 quarter
|
|
70
Calamos Convertible Opportunities and Income Fund
CHI
$920M
| $197K | 0.17% |
17,525
| – | – |
2016 Q4
2 quarters
|
|
71
iShares Gold Trust
IAU
$61.9B
| $178K | 0.16% |
7,450
| – | – |
2013 Q4
14 quarters
|
|
72
Caterpillar
CAT
$338B
| – | – |
-3,093
| Closed | -$287K | – |
|
73
Huntington Bancshares
HBAN
$31B
| – | – |
-10,000
| Closed | -$134K | – |
|
|
74
iShares Russell 2000 ETF
IWM
$77.5B
| – | – |
-7,205
| Closed | -$991K | – |
|
|
75
McKesson
MCK
$116B
| – | – |
-5,743
| Closed | -$851K | – |
|
Similar funds
TAM
RIP
CWM
LWP
FGA
BVC
APM
PIM
Bellecapital's Q2 2017 Portfolio in Review
As of Q2 2017, Bellecapital held 78 positions worth $114M, up 5.5% from $108M the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Bellecapital's Q2 2017 filing shows 3 new, 13 increased, 18 reduced and 7 closed positions. Its largest new stake was PRA Health Sciences, Inc.: 73,180 shares worth $5.49M. The largest sale was Procter & Gamble, an estimated $3.22M.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Bellecapital's largest Q2 2017 buy was PRA Health Sciences, Inc.: 73,180 shares worth $5.49M.
- Bellecapital added most to WisdomTree Japan Hedged Equity Fund in Q2 2017, an estimated $2.66M increase.
- Bellecapital's biggest Q2 2017 reduction was Procter & Gamble, cutting an estimated $3.22M.
- Bellecapital fully exited Pfizer in Q2 2017, selling an estimated $1.03M.
- Bellecapital's ten largest holdings make up 49% of its $114M portfolio in Q2 2017.
- Bellecapital opened 3 new positions and closed 7 in Q2 2017.
- Bellecapital's portfolio value rose 5.5% quarter-over-quarter to $114M.
Based on Bellecapital's 13F filing for Q2 2017, filed 26 Jul 2017.